- Erections depend on healthy blood vessels. The same damage to artery linings that drives heart disease can affect the penis, and it may show up there first
- The "years earlier" claim has a source: in 300 men with coronary artery disease, ED came before heart symptoms in 67% of those who had both, by an average of 38.8 months. Expert panels now describe a window of about 2 to 5 years
- Large studies agree on the direction. A meta-analysis of 14 studies and 92,757 men linked ED to 44% more cardiovascular events and 62% more heart attacks. The link was stronger in younger men
- Guidelines say: get checked. The American Urological Association says men should be told ED is a risk marker for heart disease, and the Princeton consensus says to treat men with ED as at risk until checks show otherwise
- Lifestyle helps both. In a 2-year trial, 31% of obese men in a weight-loss and exercise programme regained normal erectile function. ED pills must never be combined with nitrates
Most men treat erection problems as a private nuisance, something to fix with a pill or ignore. Doctors who study the heart see it differently. For many men, the arteries that supply the penis are an early place where blood vessel trouble becomes noticeable, sometimes years before chest pain or a heart attack.
That doesn't mean every man with erectile dysfunction (ED) has heart disease; stress, medicines, nerve damage and low testosterone can all play a part. But it is one of the few early signals you can actually notice. Here's what the research shows and what to raise with your doctor. It isn't medical advice.
Why the Penis and the Heart Share a Problem
Evidence: Strong for shared risk factors — the size explanation is a hypothesisAn erection is a blood-flow event. Nerves and the cells lining the penile arteries release nitric oxide, which sets off a chain (via a messenger called cGMP) that relaxes smooth muscle and lets blood rush in (Lyu, Transl Androl Urol 2025). That lining, the endothelium, is exactly what high blood pressure, smoking, diabetes and high cholesterol damage over time. A 2025 review puts it plainly: "Endothelial dysfunction is recognized as an early marker of both" atherosclerosis and ED, and once plaque develops, the endothelium is damaged and nitric oxide falls.
The US National Institute of Diabetes and Digestive and Kidney Diseases lists the overlap: blood vessel diseases "such as atherosclerosis, high blood pressure, and stroke", diabetes, overweight, smoking, inactivity and heavy drinking can all lead to or contribute to ED (NIDDK).
The "artery size" hypothesis
Why would the penis show symptoms first? In a 2005 paper, cardiologist Piero Montorsi and colleagues set out the artery size hypothesis. Atherosclerosis is a body-wide process, but "penile arteries are smaller in diameter than coronary arteries", and a larger vessel can "better tolerate the same amount of plaque compared with a smaller one" (Montorsi, Am J Cardiol 2005). The same build-up that barely narrows a heart artery could noticeably restrict a small penile one. It's plausible, not proven, and it doesn't fit every man.
Where the "2 to 5 years" figure comes from
A key early study, published in European Urology in 2003, looked at 300 consecutive patients with acute chest pain whose coronary artery disease was confirmed by angiography, average age 62.5. Using interviews and a standard questionnaire (the International Index of Erectile Function, IIEF), the team found 147 (49%) had ED. Of those, 99 (67%) said their ED had started before their heart symptoms, by an average of 38.8 months, a little over three years. The range was wide: from 1 month to 168 months (Montorsi, Eur Urol 2003).
Two cautions. The timing relied on what men recalled after they were diagnosed, and the study had no comparison group of heart patients without ED; the authors themselves said controlled studies were needed to know whether ED truly predicts heart disease. Later consensus statements summarise the evidence as "a time window between ED onset and a CAD event of 2 to 5 years" (Princeton III, Mayo Clin Proc 2012). Treat that as a typical range, not a countdown.
What the Big Studies Found
Evidence: Consistent — observational cohorts and meta-analysesA prostate trial that tracked erections
The Prostate Cancer Prevention Trial checked men every three months for both ED and cardiovascular disease between 1994 and 2003. Researchers analysed the 9,457 men aged 55 or older in the placebo group, at 221 US centres (Thompson, JAMA 2005).
- Of 8,063 men free of cardiovascular disease at the start, 3,816 (47%) already had ED.
- Of the 4,247 who didn't, 2,420 (57%) reported new ED by 5 years.
- After adjusting for age, weight, blood pressure, cholesterol, diabetes, family history, smoking, activity and more, new ED was linked to a 25% higher rate of later cardiovascular events (hazard ratio 1.25; 95% CI 1.02 to 1.53). For any ED, new or existing, it was 45% (HR 1.45).
- In raw numbers: 24 events per 1,000 person-years in men with ED at the start, against 15 in men without.
The authors said the association was "in the range of risk associated with current smoking or a family history of myocardial infarction", and concluded that ED "should prompt investigation and intervention for cardiovascular risk factors."
Pooled results from many studies
Two meta-analyses gathered the cohort studies together. In JACC in 2011, Dong and colleagues pooled 12 prospective cohort studies with 36,744 participants, followed on average for 4 to 16 years. Men with ED had higher risks of cardiovascular disease, coronary heart disease, stroke and death (Figure 1). Limiting the analysis to studies that adjusted for conventional risk factors gave similar results, though the authors noted residual confounding couldn't be ruled out (Dong, J Am Coll Cardiol 2011).
A larger 2013 meta-analysis by Vlachopoulos and colleagues in Circulation: Cardiovascular Quality and Outcomes pooled 14 studies with 92,757 participants and an average follow-up of 6.1 years (Vlachopoulos, 2013). The link with cardiovascular death on its own (relative risk 1.19) didn't reach statistical significance; the others did.
How much higher the risk was in men with ED
Gold bars: Vlachopoulos et al., Circ Cardiovasc Qual Outcomes 2013 (14 studies, 92,757 participants). Green bars: Dong et al., J Am Coll Cardiol 2011 (12 prospective cohorts, 36,744 participants). Relative risks for men with versus without ED; bar length shows the percentage increase. All shown were statistically significant. Cardiovascular death alone (RR 1.19 in the 2013 analysis) was not, and isn't shown. Observational data: associations, not proof of cause.
The signal is strongest in younger men
The 2013 meta-analysis found the extra risk was higher "with younger age" and in men at intermediate cardiovascular risk, the group where a doctor's risk estimate is least certain. It was also higher when ED was measured with a full questionnaire (RR 1.61) rather than a single question (RR 1.27).
A community study from Olmsted County, Minnesota shows the age pattern starkly. Researchers screened a random sample of 1,402 men every two years from 1996 to 2005 and recorded 156 new cases of coronary artery disease. Overall, ED was linked to roughly double the risk (hazard ratio 2.1), and adjusting for diabetes, high blood pressure, smoking and BMI didn't change that (Inman, Mayo Clin Proc 2009). The gap was by far the widest in men in their 40s:
New coronary artery disease by age and ED
| Age | Without ED | With ED |
|---|---|---|
| 40–49 | 0.94 | 48.52 |
| 50–59 | 5.09 | 27.15 |
| 60–69 | 10.72 | 23.97 |
| 70 and over | 23.30 | 29.63 |
New cases of coronary artery disease per 1,000 person-years in 1,402 men. Inman et al., Mayo Clinic Proceedings 2009. The authors concluded that "young men with ED may be ideal candidates for cardiovascular risk factor screening and medical intervention." The rate for men in their 40s with ED is very imprecise (95% CI 1.23 to 269.26).
More recent data point the same way. In the Multi-Ethnic Study of Atherosclerosis (MESA), 877 of 1,914 men (45.8%, average age 69) reported ED. Among the 1,757 without prior heart disease, followed for about 3.8 years, ED was linked to almost double the rate of hard cardiovascular events (hazard ratio 1.9; 95% CI 1.1 to 3.4) after full adjustment, though the link with coronary events alone was no longer significant (Uddin, Circulation 2018).
What Guidelines Actually Say
Evidence: Consensus and guideline statements- American Urological Association (2018). Statement 3 of its ED guideline, a Clinical Principle: "Men should be counseled that ED is a risk marker for underlying cardiovascular disease (CVD) and other health conditions that may warrant evaluation and treatment." It also recommends measuring morning total testosterone in men with ED (AUA).
- Princeton III consensus (2012). "A man with organic ED should be considered at increased CVD risk until recommended checks suggest otherwise." The panel singled out ED "especially in men aged 30 to 60 years" as a reason to look at cardiovascular risk (Nehra, Mayo Clin Proc 2012).
- Princeton IV consensus (2024). The panel, which met in Pasadena in March 2023, said evidence supports treating men with ED "as being at risk for cardiac events until proven otherwise", and added coronary artery calcium scoring to its algorithm for risk assessment (Köhler, Mayo Clin Proc 2024). According to a Mayo Clinic summary, the authors advocate calcium scoring for men with ED at borderline (5% to 7.5%) or intermediate (7.5% to 20%) 10-year risk, "especially in patients ages 40 to 60, whose risk is often underestimated" (Mayo Clinic).
- American College of Cardiology and American Heart Association (2019). The general prevention guideline says adults aged 40 to 75 being evaluated for prevention should have their 10-year risk estimated. It names erectile dysfunction among the factors that may be used to revise that estimate in people at borderline or intermediate risk, though not in its main table of "risk-enhancing factors" (Arnett, Circulation 2019).
What to Ask Your Doctor
If you've noticed erection problems, especially if you're under 60, mention them at your next check-up. These are the checks expert panels list.
What to check, and why
| Check | Why it matters | Basis |
|---|---|---|
| Blood pressure, waist size, BMI | High blood pressure and excess weight damage artery linings and are common causes of ED | Princeton III exam list |
| Lipid panel | Total, LDL and HDL cholesterol and triglycerides feed into your 10-year risk estimate the 2018 cholesterol guideline lists a high ApoB (130 mg/dL or more) as a risk-enhancing factor | Princeton III |
| Fasting glucose or A1C | Diabetes is a major cause of ED and heart disease. A1C reflects average blood sugar over 3 months; 5.7% to 6.4% is prediabetes, 6.5% or above diabetes | Princeton III; AUA; CDC |
| Morning testosterone | Low testosterone can contribute to ED and changes treatment options | AUA Statement 4; Princeton III (before 11 am) |
| 10-year cardiovascular risk estimate | Combines age, blood pressure, cholesterol, diabetes and smoking to guide decisions such as statins | ACC/AHA 2019, adults 40–75 |
| Coronary artery calcium (CAC) scan | If your risk is borderline or intermediate and a statin decision is uncertain, a CT scan for calcified plaque can move the estimate up or down | AHA/ACC 2018; ACC/AHA 2019; Princeton IV |
Princeton III (Nehra et al., Mayo Clin Proc 2012); AUA ED guideline 2018; CDC A1C guidance; 2019 ACC/AHA primary prevention guideline; 2018 AHA/ACC cholesterol guideline; Princeton IV (Köhler et al., 2024). Not every man needs every test: your doctor will choose based on your history.
About the calcium score
A calcium scan is a quick, non-contrast CT that detects calcified plaque in the heart's arteries. The 2018 cholesterol guideline says that for adults aged 40 to 75 at intermediate risk, if a decision about statin therapy is uncertain, "consider measuring CAC." A score of zero generally points to lower risk, but the 2019 guideline warns doctors not to downgrade risk on that basis in persistent smokers, people with diabetes or those with a family history of heart disease. A score of 1 to 99 "favors statin therapy, especially in those ≥55 years of age", and at 100 or more, or the 75th percentile or above for your age, "statin therapy is indicated" unless you and your doctor decide otherwise (AHA/ACC 2018; ACC/AHA 2019). Our guide to silent plaque covers the test in more detail.
Lifestyle Changes With Trial Evidence
Evidence: Moderate — randomised trials, modest numbersWeight loss and activity. In a single-blind trial in JAMA in 2004, Esposito and colleagues randomised 110 obese men aged 35 to 55 with ED (BMI 30 or more). One group got detailed advice on how to lose at least 10% of their weight by eating less and moving more; the other got general advice on healthy food and exercise (Esposito, JAMA 2004). After two years:
- BMI fell from 36.9 to 31.2 in the intervention group, against 36.4 to 35.7 in controls.
- Physical activity rose from 48 to 195 minutes a week, against 51 to 84.
- Erectile function scores (IIEF) rose from 13.9 to 17, against 13.5 to 13.6.
- 17 men in the intervention group (31%) reached a score of 22 or higher, the normal range, against 3 in the control group.
Aerobic exercise. A 2023 meta-analysis in The Journal of Sexual Medicine pooled 11 randomised trials with 1,147 men. Aerobic exercise improved erectile function scores by 2.8 points on a 6-to-30 scale compared with no exercise, and the benefit grew with severity: 2.3 points for mild ED, 3.3 for moderate and 4.9 for severe (Khera, J Sex Med 2023).
The Princeton III panel summed it up: "In all patients, lifestyle changes are likely to reduce cardiovascular risk and improve erectile function." Stopping smoking and drinking less belong on the same list, since NIDDK names both as habits that may contribute to ED. If testosterone comes up, our guide to TRT after 40 covers what the largest safety trial found.
ED Pills and Heart Medicines
PDE5 inhibitors such as sildenafil (Viagra) and tadalafil (Cialis) are prescription medicines, and the FDA labels carry warnings every man with a heart condition should know. This article gives no dosing advice; your doctor and pharmacist should check your full medication list.
- Never with nitrates. Both labels say the drugs are contraindicated in men taking organic nitrates in any form, including nitroglycerin for chest pain (the Viagra label also names nitrites), and with riociguat, a medicine for pulmonary hypertension (Viagra label; Cialis label).
- Tell emergency staff. The Cialis label says that if a nitrate is needed in a life-threatening situation, at least 48 hours should pass after the last dose; the Viagra label says it is unknown when nitrates can be safely given. If you've taken either and get chest pain, say so.
- Fitness for sex. The Viagra label says these drugs shouldn't generally be used by men for whom sexual activity is inadvisable. The Mayo Clinic's summary of Princeton IV says that if you can walk a mile or climb two flights of stairs without symptoms, sex is safe, and for men with a recent heart attack, heart failure or unstable angina, a stress test or cardiology clearance is advised before starting ED treatment.
- Other warnings. Caution with alpha-blockers (used for blood pressure and prostate symptoms). Get urgent help for an erection lasting more than 4 hours, or for sudden loss of vision or hearing.
A pill treats the symptom, not the arteries, so the check-up matters even if the pill works.
Frequently Asked Questions
Treat it as a signal, not just a symptom.
ED and heart disease share the same root problem in the artery lining, and in large studies men with ED had higher rates of heart attack, stroke and death, especially men in their 40s and 50s. It doesn't mean a heart attack is coming. It means it's worth knowing your numbers.
Talk to your doctor about blood pressure, cholesterol, blood sugar, testosterone and your 10-year risk, and whether a calcium score makes sense. Move more, lose weight if you need to, stop smoking, and never mix ED pills with nitrates.
Sources
- Montorsi F, Briganti A, Salonia A, et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. European Urology 2003;44(3):360–364 (doi:10.1016/S0302-2838(03)00305-1).
- Montorsi P, Ravagnani PM, Galli S, et al. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. American Journal of Cardiology 2005;96(12S2):19–23 (doi:10.1016/j.amjcard.2005.07.006).
- Lyu F, Long W, Ma L. Atherosclerosis-induced arterial erectile dysfunction: pathogenesis, diagnosis, and therapeutic strategies. Translational Andrology and Urology 2025;14(9):2732–2753 (doi:10.21037/tau-2025-241).
- National Institute of Diabetes and Digestive and Kidney Diseases. Symptoms & Causes of Erectile Dysfunction.
- Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005;294(23):2996–3002 (doi:10.1001/jama.294.23.2996). Abstract via NCI Early Detection Research Network.
- Dong J-Y, Zhang Y-H, Qin L-Q. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. Journal of the American College of Cardiology 2011;58(13):1378–1385 (doi:10.1016/j.jacc.2011.06.024). See also the ACC press release (September 2011).
- Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, Aznaouridis KA, Stefanadis CI. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circulation: Cardiovascular Quality and Outcomes 2013;6(1):99–109 (doi:10.1161/CIRCOUTCOMES.112.966903).
- Inman BA, St Sauver JL, Jacobson DJ, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clinic Proceedings 2009;84(2):108–113 (doi:10.4065/84.2.108).
- Uddin SMI, Mirbolouk M, Dardari Z, et al. Erectile dysfunction as an independent predictor of future cardiovascular events: the Multi-Ethnic Study of Atherosclerosis. Circulation 2018;138(5):540–542 (doi:10.1161/CIRCULATIONAHA.118.033990).
- Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. Journal of Urology 2018;200(3):633–641 (doi:10.1016/j.juro.2018.05.004).
- Nehra A, Jackson G, Miner M, et al. The Princeton III consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clinic Proceedings 2012;87(8):766–778 (doi:10.1016/j.mayocp.2012.06.015).
- Köhler TS, Kloner RA, Rosen RC, et al. The Princeton IV consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clinic Proceedings 2024;99(9):1500–1517 (doi:10.1016/j.mayocp.2024.06.002). See also HMRI (August 2024).
- Mayo Clinic. Erectile dysfunction: A vital sign for cardiovascular health. Medical professionals news, June 2025.
- Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation 2019;140(11):e596–e646 (doi:10.1161/CIR.0000000000000678).
- Grundy SM, Stone NJ, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation 2019;139(25):e1082–e1143 (doi:10.1161/CIR.0000000000000625).
- Centers for Disease Control and Prevention. A1C Test for Diabetes and Prediabetes.
- Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004;291(24):2978–2984 (doi:10.1001/jama.291.24.2978).
- Khera M, Bhattacharyya S, Miller LE. Effect of aerobic exercise on erectile function: systematic review and meta-analysis of randomized controlled trials. Journal of Sexual Medicine 2023;20(12):1369–1375 (doi:10.1093/jsxmed/qdad130).
- US Food and Drug Administration. VIAGRA (sildenafil citrate) prescribing information (revised December 2017).
- US Food and Drug Administration, FDALabel. CIALIS (tadalafil) prescribing information (version effective June 2026).